Wuxi Apptec Co., Ltd.
Records under this name other than the patents Wuxi Apptec Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,090,661 | Inhibitors of Hepatitis C Virus Replication now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 9,265,773 | Tetracyclic Heterocycle Compounds and Methods of Use Thereof for the Treatment of Viral Diseases now held by Merck Sharp & Dohme LLC In force · High confidence | In force | High confidence | |
| US 10,206,931 | Therapeutic Compounds and Uses Thereof conveyed to Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 9,763,922 | Therapeutic Compounds and Uses Thereof conveyed to Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 11,072,635 | Macrocyclic Broad Spectrum Antibiotics conveyed to Genentech, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,696,655 | Therapeutic Compounds and Uses Thereof conveyed to Genentech Inc. - now held by Constellation Pharmaceuticals, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,968,203 | Pyrimidinyl-Pyridyloxy-Naphthyl Compounds and Methods of Treating IRE1-RELATED Diseases and Disorders conveyed to Genentech Inc. - now held by The Regents of the University of California, Howard Hughes Medical Institute and Genentech, Inc. In force · High confidence | In force | High confidence | |
| US 12,312,325 | Methods and Compounds Useful in the Synthesis of an AAK1 Inhibitor now held by Lexicon Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 8,865,701 | Spiropyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease now held by Merck Sharp & Dohme LLC Lapsed on the fee record Ended Oct 21, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 21, 2026 | Low confidence |
| US 10,022,354 | Pyrrolidine Amide Compounds as Histone Demethylase Inhibitors conveyed to Genentech, Inc. Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |